| Andrew P Weiss, MD | |
|
1836 South Ave, La Crosse, WI 54601-5429 | |
| (608) 782-7300 | |
| Not Available |
| Full Name | Andrew P Weiss |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 1836 South Ave, La Crosse, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356509384 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gundersen Lutheran Medical Center | La crosse, WI | Hospital |
| Tomah Memorial Hospital | Tomah, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Lutheran Medical Center Inc | 2163331414 | 800 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20031121000846 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | Memorial Hospital Of Boscobel |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760459846 PECOS PAC ID: 8325957673 Enrollment ID: O20040115000725 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | St Joseph's Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104031798 PECOS PAC ID: 3971586439 Enrollment ID: O20040615000273 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | Tri-county Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124063573 PECOS PAC ID: 4587642418 Enrollment ID: O20040708000696 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew P Weiss, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 | Andrew P Weiss, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 |
News Archive
Also in the news, Roll Call takes a look at what action to expect, and who on Capitol Hill will be in the hot seat, as the Supreme Court works its way through the health law's constitutionality.
Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.
Medications trolleys in nursing homes may soon become mobile medical centres. The University of New South Wales has won a $300,000 grant to develop and trial a new point-of-care system that will allow nursing staff to manage medications, check patients' clinical signs and streamline administration and clinical interaction with patients' GPs.
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
› Verified 9 days ago
Raymond D Pollock, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-392-7000 Fax: 608-392-7808 | |
Dr. Marvelene Julia Casner, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 | |
Clay Arthur Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 605-787-8702 | |
Dr. Leah Rose Moellers Thompson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Taft Franklin, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 | |
Dr. Gabriel L Marsh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Andrew Ronald Jesson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |